Invention Application
WO2015094985A3 IMMUNOVIR AND COMPONENTS, IMMUNOVIR A, B, C, D UTILITY AND USEFUL PROCESSES
审中-公开
免疫和免疫组件,免疫A,B,C,D公用事业和有用过程
- Patent Title: IMMUNOVIR AND COMPONENTS, IMMUNOVIR A, B, C, D UTILITY AND USEFUL PROCESSES
- Patent Title (中): 免疫和免疫组件,免疫A,B,C,D公用事业和有用过程
-
Application No.: PCT/US2014070141Application Date: 2014-12-12
-
Publication No.: WO2015094985A3Publication Date: 2015-09-24
- Inventor: LO AMY HUIMEEI , LIN YONG CHI , LIN PO WEN , LIN PO YU , LIN JING MEEI
- Applicant: LO AMY HUIMEEI
- Assignee: LO AMY HUIMEEI
- Current Assignee: LO AMY HUIMEEI
- Priority: US201314107086 2013-12-16
- Main IPC: A01N65/00
- IPC: A01N65/00
Abstract:
A complete remedy for AIDS is difficult to obtain. As such, a useful process was designed to search for an anti-HIVi agent that has an immuno response modification activity capable of releasing immuno suppression, activating killer cells to destroy persistent infection cells, elevating antibody titer to activate ADCC activity, and vice versa. The process consists of 4 elements: guinea pig or mouse peritoneal derived adherent macrophages/monocytes as effector cells; cyclophosphamide as an immuno suppressor; chicken RBC as target cells; and the anti-HIVi agent candidate to be examined. Immunovir and components were isolated from Pyrus serotina Rehder and other species of Rosaceae by column chromatography. Another useful process is the comparison of fluorescent antibody (FA) titer patterns among one round, two round, and non-medicated infected monkeys. The results of such processes can show that the anti-HIVi agent, such as these immunovirs, are noble candidates for the complete remedy of AIDS.
Information query